TipRanks
Rising Biosciences Inc (RBII)
OTHER OTC:RBII
US Market

Rising Biosciences (RBII) Ratios

21 Followers

Rising Biosciences Ratios

See a summary of RBII’s cash flow.
Ratios
Dec 20Dec 19
Liquidity Ratios
Current Ratio
― 0.12
Quick Ratio
― 0.10
Cash Ratio
― 0.03
Solvency Ratio
― 0.05
Operating Cash Flow Ratio
― -0.04
Short-Term Operating Cash Flow Coverage
― -0.07
Net Current Asset Value
$ ―$ -1.52M
Leverage Ratios
Debt-to-Assets Ratio
― 1.65
Debt-to-Equity Ratio
― -0.97
Debt-to-Capital Ratio
― -31.66
Long-Term Debt-to-Capital Ratio
― 0.00
Financial Leverage Ratio
― -0.59
Debt Service Coverage Ratio
― 0.14
Interest Coverage Ratio
― 4.09
Debt to Market Cap
― 0.83
Interest Debt Per Share
― <0.01
Net Debt to EBITDA
― 6.60
Profitability Margins
Gross Profit Margin
―57.32%
EBIT Margin
―15.23%
EBITDA Margin
―19.52%
Operating Profit Margin
―36.33%
Pretax Profit Margin
―6.36%
Net Profit Margin
―6.36%
Continuous Operations Profit Margin
―6.36%
Net Income Per EBT
―100.00%
EBT Per EBIT
―17.51%
Return on Assets (ROA)
―7.77%
Return on Equity (ROE)
―-4.57%
Return on Capital Employed (ROCE)
―-26.08%
Return on Invested Capital (ROIC)
―-851.75%
Return on Tangible Assets
―7.77%
Earnings Yield
―3.91%
Efficiency Ratios
Receivables Turnover
― 6.46
Payables Turnover
― 6.87
Inventory Turnover
― 8.45
Fixed Asset Turnover
― 2.85
Asset Turnover
― 1.22
Working Capital Turnover Ratio
― -0.51
Cash Conversion Cycle
― 46.54
Days of Sales Outstanding
― 56.48
Days of Inventory Outstanding
― 43.21
Days of Payables Outstanding
― 53.15
Operating Cycle
― 99.69
Cash Flow Ratios
Operating Cash Flow Per Share
― >-0.01
Free Cash Flow Per Share
― >-0.01
CapEx Per Share
― <0.01
Free Cash Flow to Operating Cash Flow
― 1.00
Dividend Paid and CapEx Coverage Ratio
― -23.45K
Capital Expenditure Coverage Ratio
― -23.45K
Operating Cash Flow Coverage Ratio
― -0.07
Operating Cash Flow to Sales Ratio
― -0.09
Free Cash Flow Yield
―-5.53%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
― 25.56
Price-to-Sales (P/S) Ratio
― 1.63
Price-to-Book (P/B) Ratio
― -1.17
Price-to-Free Cash Flow (P/FCF) Ratio
― -18.08
Price-to-Operating Cash Flow Ratio
― -18.08
Price-to-Earnings Growth (PEG) Ratio
― -0.26
Price-to-Fair Value
― -1.17
Enterprise Value Multiple
― 14.93
Enterprise Value
― 2.28M
EV to EBITDA
― 14.93
EV to Sales
― 2.91
EV to Free Cash Flow
― -32.41
EV to Operating Cash Flow
― -32.41
Tangible Book Value Per Share
― >-0.01
Shareholders’ Equity Per Share
― >-0.01
Tax and Other Ratios
Effective Tax Rate
― 0.00
Revenue Per Share
― <0.01
Net Income Per Share
― <0.01
Tax Burden
― 1.00
Interest Burden
― 0.42
Research & Development to Revenue
― 0.00
SG&A to Revenue
― 0.00
Stock-Based Compensation to Revenue
― 0.00
Income Quality
― -1.41
Currency in USD